Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07572747
Aspirin Versus Clopidogrel in Chronic Coronary Syndrome in Arabian Gulf CountriesKhalid F AlhabibNot Yet RecruitingPhase 3
NCT07572747Not Yet Recruiting
Phase 3
Aspirin Versus Clopidogrel in Chronic Coronary Syndrome in Arabian Gulf Countrie...Khalid F Alhabib
NCT07572266
Adjuvant Nitrate to Boost Exercise-induced Health Benefits in Older AdultsFlorida Institute for Human and Machine CognitionNot Yet RecruitingNot Applicable
NCT07572266Not Yet Recruiting
Not Applicable
Adjuvant Nitrate to Boost Exercise-induced Health Benefits in Older AdultsFlorida Institute for Hum...
NCT07572539
The Accuracy of Peripheral Perfusion Index and Inferior Vena Cava Collapsibility Index for Predicting Hypotension in Patients Undergoing Shoulder Arthroscopy in Beach Chair Position:Tanta UniversityActive Not Recruiting
NCT07572539Active Not Recruiting
—
The Accuracy of Peripheral Perfusion Index and Inferior Vena Cava Collapsibility...Tanta University
NCT07573202
Silk Fibroin Versus 2-octyl Cyanoacrylate Mesh a Randomized Controlled Trial to Evaluate Hypersensitivity Reactions in Shoulder SurgeryThe University of Texas Health Science Center, HoustonNot Yet RecruitingNot Applicable
NCT07573202Not Yet Recruiting
Not Applicable
Silk Fibroin Versus 2-octyl Cyanoacrylate Mesh a Randomized Controlled Trial to...The University of Texas H...
NCT07572838
Alter-Ego as an Assistive Robotic Device.Istituti Clinici Scientifici Maugeri SpANot Yet Recruiting
NCT07572032
Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot StudyAjou University Medical CenterNot Yet RecruitingPhase 4
NCT07572032Not Yet Recruiting
Phase 4
Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology...Ajou University Medical C...
NCT07573241
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Complementary and Integrative Health (NCCIH)Not Yet RecruitingNot Applicable
NCT07573241Not Yet Recruiting
Not Applicable
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Compl...
NCT07572435
Preliminary Efficacy of a Remote Cardiac Rehabilitation Program in Pediatric Patients With Complex Congenital Heart DiseaseSeoul National University HospitalRecruitingNot Applicable
NCT07572435Recruiting
Not Applicable
Preliminary Efficacy of a Remote Cardiac Rehabilitation Program in Pediatric Pat...Seoul National University...
NCT07574385
Sciatic Nerve Block With ALX006 in Subjects Undergoing BunionectomyRebel Medicine IncRecruitingPhase 2
NCT07574385Recruiting
Phase 2
Sciatic Nerve Block With ALX006 in Subjects Undergoing BunionectomyRebel Medicine Inc
NCT07574112
Muscle Energy Technique With And Without Myofascial Release in Patients With Cervicogenic HeadacheUniversity of LahoreCompletedNot Applicable
NCT07574112Completed
Not Applicable
Muscle Energy Technique With And Without Myofascial Release in Patients With Cer...University of Lahore
NCT07572292
Proof of Concept for Simulating Static Weight-bearing Exercises in the Supine PositionVrije Universiteit BrusselNot Yet RecruitingNot Applicable
NCT07572292Not Yet Recruiting
Not Applicable
Proof of Concept for Simulating Static Weight-bearing Exercises in the Supine Po...Vrije Universiteit Brusse...
NCT07572851
Functional Changes and Fall Risk in Older Adults Participating in a Frailty ProgramUniversity of VigoEnrolling By Invitation
NCT07572851Enrolling By Invitation
—
Functional Changes and Fall Risk in Older Adults Participating in a Frailty Prog...University of Vigo
NCT07572136
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-cell Acute Lymphoblastic Leukemia (B-ALL)National Cancer Institute (NCI)Not Yet RecruitingPhase 1
NCT07572136Not Yet Recruiting
Phase 1
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T...National Cancer Institute...
NCT07572526
tDCS: Sleep to Mood in Depression (S2M-D)NYU Langone HealthNot Yet RecruitingNot Applicable
NCT07572526Not Yet Recruiting
Not Applicable
tDCS: Sleep to Mood in Depression (S2M-D)NYU Langone Health
NCT07574281
Effectiveness and Implementation of the DINKNESH Digital Palliative Care Tool in EthiopiaAddis Ababa UniversityNot Yet RecruitingNot Applicable
NCT07574281Not Yet Recruiting
Not Applicable
Effectiveness and Implementation of the DINKNESH Digital Palliative Care Tool in...Addis Ababa University
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07572318
Pilot Study on the Feasibility of High-energy Collimation With Optimized Geometry on a VERITON™ CZT CameraCentral Hospital, Nancy, FranceNot Yet RecruitingNot Applicable
NCT07572318Not Yet Recruiting
Not Applicable
Pilot Study on the Feasibility of High-energy Collimation With Optimized Geometr...Central Hospital, Nancy,...
NCT07574268
Efficacy of Transcutaneous Electrical Neural Stimulation and Tadalafil in Men With Erectile Dysfunction: A Randomized, Double-Blind, Bi-centric, Placebo- and Sham-Controlled TrialMenoufia UniversityCompletedPhase 4
NCT07574268Completed
Phase 4
Efficacy of Transcutaneous Electrical Neural Stimulation and Tadalafil in Men Wi...Menoufia University
NCT07573449
How [14C]-JNT-517 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Healthy Male ParticipantsOtsuka Pharmaceutical Development & Commercialization, Inc.CompletedPhase 1
NCT07573449Completed
Phase 1
How [14C]-JNT-517 is Absorbed, Broken Down, and Removed From the Body After a Si...Otsuka Pharmaceutical Dev...
Result Breakdown
Not yet recruiting12 (60%)
Completed4 (20%)
Recruiting2 (10%)
Active, not recruiting1 (5%)
Enrolling by invitation1 (5%)
not_applicable10 (50%)
Not Specified4 (20%)
Phase 42 (10%)
Phase 12 (10%)
Phase 31 (5%)
Phase 21 (5%)